Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Leah E. Hendrick"'
Autor:
Jeremiah L. Deneve, Justin J. Monroe, Evan S. Glazer, David Shibata, Leah E. Hendrick, Paxton V. Dickson, Denise L. Wong, Nathan M. Hinkle, Whitney M. Guerrero
Publikováno v:
The American Journal of Surgery. 222:395-401
BACKGROUND Practice guidelines recommend neoadjuvant chemoradiation (NCR) for locally advanced rectal cancer (LARC). We examined guideline adherence in a healthcare system serving a region with socioeconomic disparities and poor cancer outcomes. METH
Autor:
Marcus A. Alvarez, Lorraine M. Albritton, David Shibata, Ajeeth K. Pingili, Jeremiah L. Deneve, Rita Kansal, D. Neil Hayes, Evan S. Glazer, S. Mazher Hussain, Danny Yakoub, Gustavo A. Miranda-Carboni, Leah E. Hendrick, Michio Kurosu, TJ Hollingsworth, Paxton V. Dickson, Liza Makowski, Abul Elahi
Publikováno v:
Cellular Oncology. 44:673-687
The transforming growth factor-beta (TGF-β) pathway plays a paradoxical, context-dependent role in pancreatic ductal adenocarcinoma (PDAC): a tumor-suppressive role in non-metastatic PDAC and a tumor-promotive role in metastatic PDAC. We hypothesize
Publikováno v:
Journal of the American College of Surgeons. 235:S65-S66
Autor:
Anders Berglund, Clarisse Muenyi, Erin M. Siegel, Abidemi Ajidahun, Steven A. Eschrich, Denise Wong, Leah E. Hendrick, Ryan M. Putney, Sungjune Kim, D. Neil Hayes, David Shibata
Publikováno v:
Cancer Epidemiol Biomarkers Prev
Background: Epigenetic changes associated with human papillomavirus (HPV)–driven tumors have been described; however, HPV type–specific alterations are less well understood. We sought to compare HPV16-specific methylation changes with those in vi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::303729cc8402863cafbbea90009c362e
https://europepmc.org/articles/PMC8983563/
https://europepmc.org/articles/PMC8983563/
Autor:
Leah E. Hendrick, Xin Huang, William P. Hewgley, Luke Douthitt, Paxton V. Dickson, Evan S. Glazer, Stephen W. Behrman, David Shibata, Jeremiah L. Deneve
Publikováno v:
The American surgeon. 88(5)
Background Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is associated with significant operative time, hospital resources, and morbidity. We examine factors associated with hospital length of stay (LOS) and early ov
Autor:
Leah E. Hendrick, Renee L. Levesque, Jeremiah L. Deneve, Nathan M. Hinkle, David Shibata, Danny Yakoub, Paxton V. Dickson, Evan S. Glazer, Justin J. Monroe
Publikováno v:
World Journal of Surgery. 44:973-979
In the USA, most patients with clinical stage II/III rectal cancer receive neoadjuvant chemoradiation (chemo/XRT) over 5–6 weeks followed by a 6–10-week break before proctectomy. As chemotherapy is delivered at radio-sensitizing doses, there is e
Autor:
Leah E. Hendrick, Benjamin R. Zambetti, Denise L. Wong, Paxton V. Dickson, Evan S. Glazer, David Shibata, Martin D. Fleming, Miriam Tsao, David C. Portnoy, Jeremiah L. Deneve
Publikováno v:
Journal of surgical oncologyREFERENCES. 125(8)
Visceral angiosarcoma is rare and aggressive, accounting for 2% of soft tissue sarcomas. Using a national data set, we examine determinants of outcomes for patients presenting with this rare disease.The 2004-2015 National Cancer Database was queried
Publikováno v:
Annals of Transplantation
Iliac artery calcification is a common phenomenon complicating renal transplantation, particularly in those with diabetes. The potential for vascular clamp injury can threaten the renal allograft, ipsilateral lower extremity, or both. Utilization of
Autor:
Justin J. Monroe, Paxton V. Dickson, Nathan M. Hinkle, David Shibata, Jacob D Buckner, Evan S. Glazer, Jeremiah L. Deneve, Whitney M. Guerrero, Leah E. Hendrick
Publikováno v:
The American surgeon. 87(2)
Background In the United States, patients with clinical stage II or III rectal cancer typically receive neoadjuvant chemoradiation therapy (chemo/XRT) over a 5-6 week period followed by a 6-10 week break prior to proctectomy. In the current study, we
Autor:
David Shibata, Jonathan M. Hernandez, Abidemi Ajidahun, Abul Elahi, Leah E. Hendrick, Irina Getun, Leigh Ann Humphries
Publikováno v:
J Surg Res
Background Hyperplastic polyposis protein 1 (HPP1) encodes a tumor-suppressive transmembrane cleavable epidermal growth factor–like ligand. It is unclear as to whether cleavage and shedding of HPP1 are essential steps in achieving its tumor suppres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e986af6cb9244c08d190768346de946
https://europepmc.org/articles/PMC7483406/
https://europepmc.org/articles/PMC7483406/